Bandhan Short Term Fund vs Mahindra Manulife Short Term Fund
Bandhan Short Term Fund (Direct) and Mahindra Manulife Short Term Fund (Direct) head to head: growth of ₹100, returns across every window, risk, cost, and portfolio overlap — every figure computed from AMFI NAV history, nothing supplied by a fund house. Both are Short Duration Fund schemes — see the best short duration mutual funds for the full ranking.
Head to head
NAVs as of 09 Oct 2026
Growth of ₹100 (rebased over the selected window)
Common period 25 Feb 2021 – 09 Oct 2026, limited by Mahindra Manulife Short Term Fund. Every series is rebased to ₹100 at the start of this window.
View as table
| Date | Bandhan Short Term Fund | Mahindra Manulife Short Term Fund |
|---|---|---|
| 25 Feb 2021 | ₹100.00 | ₹100.00 |
| 15 Aug 2021 | ₹102.85 | ₹102.96 |
| 02 Feb 2022 | ₹104.19 | ₹104.63 |
| 23 Jul 2022 | ₹105.26 | ₹105.78 |
| 10 Jan 2023 | ₹108.06 | ₹108.74 |
| 30 Jun 2023 | ₹111.89 | ₹112.67 |
| 18 Dec 2023 | ₹115.51 | ₹116.48 |
| 06 Jun 2024 | ₹119.67 | ₹120.80 |
| 24 Nov 2024 | ₹124.32 | ₹125.73 |
| 14 May 2025 | ₹130.82 | ₹132.07 |
| 01 Nov 2025 | ₹134.41 | ₹136.01 |
| 21 Apr 2026 | ₹137.87 | ₹139.29 |
| 09 Oct 2026 | ₹141.90 | ₹142.92 |
| Metric | Bandhan · Direct NAV ₹66.00 Low to Moderate risk ★★★☆☆ | Mahindra Manulife · Direct NAV ₹14.30 Low to Moderate risk ★★★★☆ | Category median Short Duration Fund · 24 funds |
|---|---|---|---|
| +5.82%Best in row | +5.41% | +4.96% | |
| +7.85% | +7.79% | +7.48% | |
| +6.52% | +6.63%Best in row | +6.44% | |
| +7.10% | — | +6.97% | |
| +7.76% | +6.56% | +7.35% | |
| +7.21% | +7.17% | — | |
| +7.66%Best in row | +7.28% | +7.47% | |
| +7.50%Best in row | +6.67% | +7.30% | |
| +7.56% | — | +7.56% | |
| Risk | |||
| 1.01% | 0.93% | 0.95% | |
| 1.33 | 1.39Best in row | 0.96 | |
| 2.09 | 2.14Best in row | 1.58 | |
| -2.55% | -1.10% | -2.45% | |
| 0.39% | 0.33%Best in row | 0.37% | |
| ₹9,041Cr | — | ₹657.71Cr | |
| ₹100 | ₹500 | — | |
| Suyash Choudhary · 15.6y | Rahul Pal · 5.6y | — | |
| 03 Jan 2013 | 25 Feb 2021 | — | |
| 12.9% | 4.0% | — | |
11 rows carry the same value for every fund — show
- Benchmark
- —
- Alpha
- —
- Beta
- —
- Upside capture
- —
- Downside capture
- —
- Exit load
- None
- Lock-in
- None
- Min lumpsum
- ₹1.00K
- Portfolio turnover
- —
- Holdings
- —
- Top 10 weight
- —
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.
Frequently asked questions
Which fund has delivered higher returns — Bandhan Short Term Fund or Mahindra Manulife Short Term Fund?
Over the last 3 years, Bandhan Short Term Fund returned +7.85% CAGR against Mahindra Manulife Short Term Fund's +7.79%, computed from AMFI NAV history. Over 5 years: Bandhan Short Term Fund +6.52% vs Mahindra Manulife Short Term Fund +6.63% CAGR. Past returns don't guarantee future performance.
Which fund is cheaper — Bandhan Short Term Fund or Mahindra Manulife Short Term Fund?
Mahindra Manulife Short Term Fund has the lower expense ratio: Bandhan Short Term Fund charges 0.39% a year against Mahindra Manulife Short Term Fund's 0.33%. The expense ratio is deducted from the NAV daily, so a lower one compounds in the investor's favour.
Which fund is riskier — Bandhan Short Term Fund or Mahindra Manulife Short Term Fund?
Bandhan Short Term Fund has shown higher volatility (+1.01% annualized vs Mahindra Manulife Short Term Fund's +0.93%), measured as the annualized standard deviation of daily returns over the trailing 3 years. Worst 3-year drawdown: Bandhan Short Term Fund -0.57% vs Mahindra Manulife Short Term Fund -0.44%.
Are Bandhan Short Term Fund and Mahindra Manulife Short Term Fund in the same category?
Yes — both are Short Duration Fund schemes, so their returns, risk and cost are directly comparable against the same peer set.
Figures update daily from AMFI NAV history; ratings and ranks are WealthTicker’s own — see the methodology. This is data, not investment advice.